Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden
Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Open Heart. 2024 Sep 13;11(2):e002833. doi: 10.1136/openhrt-2024-002833.
To determine the frequency of pregnancy complications and their association with the risk of cardiovascular outcomes in women with structural heart disease (SHD).
This nationwide registry-based cohort study included women in Sweden with SHD (pulmonary arterial hypertension, congenital heart disease or acquired valvular heart disease) with singleton births registered in the national Medical Birth Register (MBR) between 1973 and 2014. Exposures were pregnancy complications; pre-eclampsia/gestational hypertension (PE/gHT), preterm birth and small for gestational age (SGA) collected from MBR. The outcomes were cardiovascular mortality and hospitalisations defined from the Cause of Death Register and the National Patient Register. Cox regression models were performed with time-dependent covariates, to determine the possible association of pregnancy complications for cardiovascular outcomes.
Among the total of 2 134 239 women included in the MBR, 2554 women with 5568 singleton births were affected by SHD. Women without SHD (N=2 131 685) were used as a reference group. PE/gHT affected 5.8% of pregnancies, preterm birth 9.7% and SGA 2.8%. Preterm birth (adjusted HR, aHR 1.91 (95% CI 1.38 to 2.64)) was associated with an increased risk of maternal all-cause mortality. PE/gHT (aHR 1.64 (95% CI 1.18 to 2.29)) and preterm birth (aHR 1.56 (95% CI 1.19 to 2.04)) were associated with an increased risk of hospitalisations for atherosclerotic CVD.
Pregnancy complications were frequent in women with SHD. With a median follow-up time of 22 years, preterm birth was associated with a higher risk of cardiovascular mortality, and PE/gHT and preterm birth were associated with cardiovascular morbidity. In women with SHD, pregnancy complications may provide additional information for the risk assessment of future cardiovascular outcomes.
为了确定妊娠并发症的频率及其与结构性心脏病(SHD)女性心血管结局风险的关系。
这项基于全国登记的队列研究纳入了瑞典患有 SHD(肺动脉高压、先天性心脏病或获得性瓣膜性心脏病)的女性,她们的单胎分娩于 1973 年至 2014 年期间在全国医疗出生登记处(MBR)登记。暴露因素为妊娠并发症;PE/gHT、早产和胎儿生长受限(SGA)从 MBR 中收集。心血管死亡率和住院治疗由死因登记处和国家患者登记处确定。使用时依变量 Cox 回归模型来确定妊娠并发症与心血管结局之间的可能关联。
在 MBR 中总共纳入了 2134239 名女性,其中 2554 名患有 5568 例单胎分娩的女性患有 SHD。未患有 SHD 的女性(N=2131685)被用作参考组。PE/gHT 影响了 5.8%的妊娠,早产 9.7%,SGA 2.8%。早产(调整后的 HR,aHR 1.91(95%CI 1.38 至 2.64))与产妇全因死亡率增加相关。PE/gHT(aHR 1.64(95%CI 1.18 至 2.29))和早产(aHR 1.56(95%CI 1.19 至 2.04))与动脉粥样硬化性 CVD 住院治疗风险增加相关。
妊娠并发症在 SHD 女性中很常见。中位随访时间为 22 年,早产与心血管死亡率增加相关,PE/gHT 和早产与心血管发病率增加相关。在患有 SHD 的女性中,妊娠并发症可能为未来心血管结局的风险评估提供额外信息。